TRHC Executive Brian Adams Receives CFO of the Year Honor

Brian Adams, CFO

Moorestown, NJ, July 29, 2019 – Tabula Rasa HealthCare (NASDAQ: TRHC) Chief Financial Officer Brian Adams received Philadelphia Business Journal’s CFO of the Year Award July 19 at a festive celebration in Philadelphia, PA. The award recognizes “outstanding financial professionals in the Philadelphia region for their roles as financial stewards.”

Adams joined TRHC in 2011 as Director of Finance as the young Company was starting to serve its first clients. He was named CFO in 2014 and currently leads the finance, accounting, treasury and risk management functions.

During his tenure, Adams has guided the company through a series of successful debt and equity financings, and designed and implemented a plan to achieve profitability. He has engineered eleven strategic acquisitions, including six in 2018 and one in 2019.

“With Brian’s financial acumen and prowess, TRHC has acquired and integrated numerous acquisitions over the last few years,” said TRHC Chairman and CEO, Calvin H. Knowlton, PhD. “In 2016, he led TRHC through its IPO, which was recognized as one of the Region’s three Investment Deals of the Year. TRHC would not be where it is today without Brian’s expertise and guidance.”

Prior to joining TRHC, Adams held leadership roles in the finance and accounting functions at both excelleRx and KPMG.

According to Editor-in-Chief, Craig Ey, “The Philadelphia Business Journal CFO of the Year Awards honor the best and the brightest. These executives exemplify the professionalism, integrity, resilience, mastery of all the financial and people skills that make a great CFO.”

Adams was named one of the region’s Top CFOs in 2015 by South Jersey Biz Magazine and, in 2014, was honored as a CFO of the Year by the New Jersey Tech Council.

About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and organizational performance solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.

Forward-Looking Statement
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. These forward-looking statements include, among other things, our goals and expectations regarding the combined company and the integration of PW into TRHC, the expected synergies from the combined company and the expected financial and operating performance of TRHC following the completion of the acquisition. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the risk that we may not be able to achieve our expectations for the combined companies due to challenges in integration and inability to retain key employees; fluctuations in our financial results; the acceptance and use of our products and services by PACE organizations and pharmacies; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; our ability to maintain relationships with a specified drug wholesaler; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; the requirements of being a public company; our ability to recognize the expected benefits from acquisitions on a timely basis or at all; and the other risk factors set forth from time to time in our filings with the Securities and Exchange Commission (“SEC”), including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

Media Contact
Dianne Semingson
dsemingson@trhc.com
T: (215) 870-0829

Investors
Bob East or Asher Dewhurst
Westwicke Partners
tabularasa@westwicke.com
T: (443) 213-0500